7UXD image
Entry Detail
PDB ID:
7UXD
Keywords:
Title:
Crystal structure of APOBEC3G Catalytic domain complex with ssDNA containing 2'-deoxy Zebularine.
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2022-05-05
Release Date:
2022-12-14
Method Details:
Experimental Method:
Resolution:
1.50 Å
R-Value Free:
0.19
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:DNA dC->dU-editing enzyme APOBEC-3G
Mutations:P200A, L234K, N236A, C243A, P247K, F310K, Q318K, C321A, Q322A, C356A
Chain IDs:A
Chain Length:199
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide
Description:DNA (5'-D(*AP*AP*TP*CP*CP*(DDN)P*AP*AP*A)-3')
Chain IDs:B
Chain Length:9
Number of Molecules:1
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Structure of the catalytically active APOBEC3G bound to a DNA oligonucleotide inhibitor reveals tetrahedral geometry of the transition state.
Nat Commun 13 7117 7117 (2022)
PMID: 36402773 DOI: 10.1038/s41467-022-34752-1

Abstact

APOBEC3 proteins (A3s) are enzymes that catalyze the deamination of cytidine to uridine in single-stranded DNA (ssDNA) substrates, thus playing a key role in innate antiviral immunity. However, the APOBEC3 family has also been linked to many mutational signatures in cancer cells, which has led to an intense interest to develop inhibitors of A3's catalytic activity as therapeutics as well as tools to study A3's biochemistry, structure, and cellular function. Recent studies have shown that ssDNA containing 2'-deoxy-zebularine (dZ-ssDNA) is an inhibitor of A3s such as A3A, A3B, and A3G, although the atomic determinants of this activity have remained unknown. To fill this knowledge gap, we determined a 1.5 Å resolution structure of a dZ-ssDNA inhibitor bound to active A3G. The crystal structure revealed that the activated dZ-H2O mimics the transition state by coordinating the active site Zn2+ and engaging in additional stabilizing interactions, such as the one with the catalytic residue E259. Therefore, this structure allowed us to capture a snapshot of the A3's transition state and suggests that developing transition-state mimicking inhibitors may provide a new opportunity to design more targeted molecules for A3s in the future.

Legend

Protein

Chemical

Disease

Primary Citation of related structures